Inventor · disambiguated record
James Jaquith
Also filed as: JAQUITH JAMES · JAQUITH JAMES B · JAQUITH JAMES BRIAN
23 granted patents·19 pending applications·107 citations·filing 2001–2025
94Inventor score
Files withAEGERA THERAPEUTICS INC18LAURENT ALAIN7JAQUITH JAMES B4PHARMASCIENCE INC3ADMARE THERAPEUTICS SOC2
Top patents by PatentIndex Score
42 records- 0195US7579320B2IAP BIR domain binding compoundsAEGERA THERAPEUTICS INC·Filed 2007·Granted Aug 25, 2009·41 cites·12 claims
- 0288US7772177B2BIR domain binding compoundsAEGERA THERAPEUTICS INC·Filed 2006·Granted Aug 10, 2010·16 cites·19 claims
- 0388US7645741B2IAP BIR domain binding compoundsAEGERA THERAPEUTICS INC·Filed 2007·Granted Jan 12, 2010·9 cites·47 claims
- 0487US7547724B2IAP BIR domain binding compoundsAEGERA THERAPEUTICS INC·Filed 2006·Granted Jun 16, 2009·12 cites·15 claims
- 0582US8063095B2IAP BIR domain binding compoundsLAURENT ALAIN·Filed 2006·Granted Nov 22, 2011·6 cites·57 claims
- 0677US11279732B2Somatostatin receptor antagonist compounds and methods of using the sameCDRD VENTURES INC·Filed 2017·Granted Mar 22, 2022·5 cites·48 claims
- 0777US8163792B2IAP BIR domain binding compoundsLAURENT ALAIN·Filed 2007·Granted Apr 24, 2012·3 cites·28 claims
- 0876US2025122207A1Ap2 associated kinase 1 inhibitors and uses thereofSATELLOS BIOSCIENCE INC·Filed 2024·Application pending·0 cites
- 0974US7714003B2Imidazo[2,1-b ]-1,3,4-thiadiazole sulfonamidesAEGERA THERAPEUTICS INC·Filed 2007·Granted May 11, 2010·1 cites·21 claims
- 1074US7129250B2Neuroprotective and anti-proliferative compoundsAEGERA THERAPEUTICS INC·Filed 2003·Granted Oct 31, 2006·7 cites·9 claims
- 1172US7795298B2IAP BIR domain binding compoundsAEGERA THERAPEUTICS INC·Filed 2006·Granted Sep 14, 2010·1 cites·33 claims
- 1269US8575113B2BIR domain binding compoundsJARVIS SCOTT·Filed 2010·Granted Nov 5, 2013·3 cites·25 claims
- 1369US7230019B2Imidazo [2,1-b]-1,3,4-thiadiazole sulfonamidesAEGERA THERAPEUTICS INC·Filed 2002·Granted Jun 12, 2007·3 cites·5 claims
- 1468US2010221261A1Iap bir domain binding compoundsAEGERA THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 1568US2025270222A1Ap2 associated kinase 1 inhibitors and uses thereofSATELLOS BIOSCIENCE INC·Filed 2025·Application pending·0 cites
- 1664US7700635B2Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamidesAEGERA THERAPEUTICS INC·Filed 2007·Granted Apr 20, 2010·0 cites·6 claims
- 1763US2009042953A1IMIDAZO [2,1,-b]-1,3,4-THIADIAZOLE SULFONAMIDESAEGERA THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 1862US9365614B2IAP BIR domain binding compoundsPHARMASCIENCE INC·Filed 2014·Granted Jun 14, 2016·0 cites·35 claims
- 1960US2024239790A17-Morpholino-1,6-Naphthyridin-5-yl Derivatives and Pharmaceutical Compositions Thereof Useful as DNA-PK InhibitorADMARE THERAPEUTICS SOC·Filed 2022·Application pending·0 cites
- 2060US2024246960A17-Morpholino-L,6-Naphthyridin-5-yl Derivatives and Pharmaceutical Compositions Thereof Useful as DNA-PK InhibitorADMARE THERAPEUTICS SOC·Filed 2022·Application pending·0 cites
- 2159US8765681B2IAP BIR domain binding compoundsPHARMASCIENCE INC·Filed 2012·Granted Jul 1, 2014·0 cites·33 claims
- 2259US7772260B2Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamidesAEGERA THERAPEUTICS INC·Filed 2006·Granted Aug 10, 2010·0 cites·22 claims
- 2359US7741349B2Imidazo[2, 1-b]-1,3,4-thiadiazole sulfonamidesAEGERA THERAPEUTICS INC·Filed 2006·Granted Jun 22, 2010·0 cites·6 claims
- 2457US12486302B2Somatostatin receptor antagonist compounds and methods of using the sameCDRD VENTURES INC·Filed 2021·Granted Dec 2, 2025·0 cites·53 claims
- 2553US2006199835A1Neuroprotective and anti-proliferative compoundsJAQUITH JAMES B·Filed 2004·Application pending·0 cites
- 2653US2011177060A1Iap bir domain binding compoundsAEGERA THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 2750US2011117081A1Functionalized pyrrolidines and use thereof as iap inhibitorsAEGERA THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 2850US2011171171A1Bridged secondary amines and use thereof as iap bir domain binding compoundsAEGERA THERAPEUTICS INC·Filed 2009·Application pending·0 cites
- 2948US2010203012A1Iap bir domain binding compoundsAEGERA THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 3047US8648094B2IAP BIR domain binding compoundsLAURENT ALAIN·Filed 2012·Granted Feb 11, 2014·0 cites·38 claims
- 3147US2007112043A1Acylated and non-acylated imidazo[2,1-b]-1,3,4,-thiadiazole-2-sulfonamides, and uses thereofJAQUITH JAMES B·Filed 2004·Application pending·0 cites
- 3246US2009179638A1Assay for identifying inhibitors of neuronal apoptotic pathwaysAEGERA THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 3346US2012009141A1Functionalized pyrrolidines and use thereof as iap inhibitorsLAURENT ALAIN·Filed 2009·Application pending·0 cites
- 3444US2006234987A1Neuroprotective benzo 1 3 oxathiol 2 onesJAQUITH JAMES B·Filed 2004·Application pending·0 cites
- 3542US9796716B2Selective inhibitors of Tec and Src protein kinase familiesPHARMASCIENCE INC·Filed 2013·Granted Oct 24, 2017·0 cites·20 claims
- 3642US2006135571A1Imidazo(2,1-b)-1,3,4-thiadiazole sulfoxides and sulfonesJAQUITH JAMES B·Filed 2004·Application pending·0 cites
- 3740US9624239B2Protein kinase inhibitorsLAURENT ALAIN·Filed 2012·Granted Apr 18, 2017·0 cites·13 claims
- 3840US9284318B2Protein kinase inhibitorsLAURENT ALAIN·Filed 2012·Granted Mar 15, 2016·0 cites·20 claims
- 3940US2004102467A1Neuroprotective and anti-proliferative compoundsFiled 2001·Application pending·0 cites
- 4033US2018312493A1Antibiotic Compounds, Pharmaceutical Formulations Thereof And Methods And Uses ThereforUNIV FRASER SIMON·Filed 2016·Application pending·0 cites
- 4131US9284350B2IAP BIR domain binding compoundsLAURENT ALAIN·Filed 2011·Granted Mar 15, 2016·0 cites·39 claims
- 4226US2017216252A1Anti-bacterial pyruvate kinase modulator compounds, compositions, uses and methodsUNIV FRASER SIMON·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James Jaquith files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →